Technological advances in interventional cardiac catheterization offer less invasive treatment options for congenital heart disease, improving short-term recovery but requiring further study for long-term outcomes.
Answers are grounded in this paper and cite their sources.
May expand less invasive options for congenital heart disease; leaves long-term outcomes open for prospective study.
As a result of recent technological advances, more types of congenital heart disease are amenable to treatment in the cardiac catheter laboratory than ever before.1 Improved imaging techniques allow for better selection of patients, and the development of a wide range of devices specifically for use in children means that many patients can avoid surgery altogether, while those with complex congenital heart disease may require fewer or less complex surgical procedures.2 This allows for a quicker recovery and a shorter hospital stay, and gives many patients an improved quality of life in the short to medium term. However, the long term outcome for many of the newer forms of intervention is still unknown.
No takes yet. Share an insight, caveat, or question.
Rachel Andrews (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: